Liver Injury and Use of Contrast-Enhanced Ultrasound for Evaluating Intrahepatic Recurrence in a Case of TACE-Refractory Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab Combination Therapy: A Case Report

A 67-year-old male with type 2 diabetes (T2DM) was diagnosed with postoperative intrahepatic recurrence for hepatocellular carcinoma (HCC). Nine sessions of transarterial chemoembolization (TACE) proved ineffective, and the patient was diagnosed as having TACE-refractory disease and received seven c...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiyama, Satoshi, Numata, Kazushi, Ogushi, Katsuaki, Chuma, Makoto, Tanaka, Reiko, Chiba, Sawako, Otani, Masako, Inayama, Yoshiaki, Nakano, Masayuki, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392634/
https://www.ncbi.nlm.nih.gov/pubmed/34441328
http://dx.doi.org/10.3390/diagnostics11081394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392634/
https://www.ncbi.nlm.nih.gov/pubmed/34441328
http://dx.doi.org/10.3390/diagnostics11081394

Ejemplares similares